Active — Not RecruitingNot Applicable

Digitally-Captured Step Counts for Evaluating Performance Status in Advanced Cancer Patients

United States80 participantsStarted 2018-12-05

Plain-language summary

The purpose of this study is to examine the relationships between objectively measured physical activity and provider-assessed and patient-reported functional outcomes in patients with advanced cancer. Findings from this study will help us better understand how change in daily physical activity, as measured using the wearable activity monitor, is related to change in a patient's functional status and clinical condition.

Who can participate

Age range18 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Diagnosis of advanced (stage 3 or 4) cancer of any type * Ambulatory (use of walking aids, such as cane and rollator, is acceptable) * Access to a device that has the capability to sync to the Fitbit * Expected to have standard of care oncology appointments at least once every 8 weeks (+/-7 days). * Have an understanding, ability, and willingness to fully comply with study procedures and restrictions * English or Spanish speaking * Ability to consent * Informed consent obtained from subject and ability for subject to comply with the requirements of the study. Exclusion Criteria: * Allergy to surgical steel or elastomer/rubber * Using a pacemaker, implantable cardiac defibrillator, neurostimulator, implantable hearing aids, cochlear implants, or other electronic medical equipment. However, removable hearing aids are permitted.

What they're measuring

Absolute change in average step counts at 8 weeks from baseline

Timeframe: 8 weeks

Absolute change in provider-assessed ECOG Performance Status at 8 weeks from baseline

Timeframe: 8 weeks

Trial details

NCT IDNCT03757182

SponsorCedars-Sinai Medical Center

Sponsor typeOTHER

Study typeOBSERVATIONAL

Primary completion2024-12-31